ADAM12 and Alzheimer disease: While we failed to detect ADAM12 in both the two groups, the circulating level of COL5A1 was significantly enhanced in the AD group (AD vs Ctrl, p < 0.01, Figure 9B), suggesting COL5A1 as a potential diagnostic marker for AD.